IL51627A - Aminoalkylene benzimidazolidin-2-one,tetrahydroquinole-2-one,benzoxazol-2-one,1,4-benyoxazine-3-one and phenylimidazolidin-2-one derivatives,their preparation and pharmaceuti-cal compositions containing them - Google Patents

Aminoalkylene benzimidazolidin-2-one,tetrahydroquinole-2-one,benzoxazol-2-one,1,4-benyoxazine-3-one and phenylimidazolidin-2-one derivatives,their preparation and pharmaceuti-cal compositions containing them

Info

Publication number
IL51627A
IL51627A IL51627A IL5162777A IL51627A IL 51627 A IL51627 A IL 51627A IL 51627 A IL51627 A IL 51627A IL 5162777 A IL5162777 A IL 5162777A IL 51627 A IL51627 A IL 51627A
Authority
IL
Israel
Prior art keywords
tetrahydroquinole
benyoxazine
benzimidazolidin
phenylimidazolidin
pharmaceuti
Prior art date
Application number
IL51627A
Other languages
English (en)
Other versions
IL51627A0 (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IL51627A0 publication Critical patent/IL51627A0/xx
Publication of IL51627A publication Critical patent/IL51627A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
IL51627A 1976-03-09 1977-03-08 Aminoalkylene benzimidazolidin-2-one,tetrahydroquinole-2-one,benzoxazol-2-one,1,4-benyoxazine-3-one and phenylimidazolidin-2-one derivatives,their preparation and pharmaceuti-cal compositions containing them IL51627A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762609645 DE2609645A1 (de) 1976-03-09 1976-03-09 Aminoalkylheterocyclen

Publications (2)

Publication Number Publication Date
IL51627A0 IL51627A0 (en) 1977-05-31
IL51627A true IL51627A (en) 1980-10-26

Family

ID=5971857

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51627A IL51627A (en) 1976-03-09 1977-03-08 Aminoalkylene benzimidazolidin-2-one,tetrahydroquinole-2-one,benzoxazol-2-one,1,4-benyoxazine-3-one and phenylimidazolidin-2-one derivatives,their preparation and pharmaceuti-cal compositions containing them

Country Status (36)

Country Link
US (4) US4154829A (xx)
JP (2) JPS52108970A (xx)
AT (1) AT360542B (xx)
AU (1) AU515953B2 (xx)
BE (1) BE852223A (xx)
BG (4) BG28051A4 (xx)
CA (1) CA1086317A (xx)
CH (8) CH630358A5 (xx)
CS (2) CS220320B2 (xx)
DD (1) DD130037A5 (xx)
DE (1) DE2609645A1 (xx)
DK (1) DK102177A (xx)
ES (10) ES456622A1 (xx)
FI (1) FI69070C (xx)
FR (2) FR2343731A1 (xx)
GB (1) GB1571231A (xx)
GR (1) GR64553B (xx)
HK (1) HK12884A (xx)
HU (1) HU177953B (xx)
IE (1) IE45300B1 (xx)
IL (1) IL51627A (xx)
LU (1) LU76898A1 (xx)
MX (1) MX4878E (xx)
MY (1) MY8500079A (xx)
NL (1) NL7702403A (xx)
NO (1) NO147950C (xx)
NZ (1) NZ183536A (xx)
PH (3) PH16110A (xx)
PL (2) PL112937B1 (xx)
PT (1) PT66282B (xx)
RO (3) RO70569A (xx)
SE (1) SE435059B (xx)
SG (1) SG55583G (xx)
SU (4) SU698530A3 (xx)
YU (1) YU62377A (xx)
ZA (1) ZA771412B (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
DK187880A (da) 1979-05-04 1980-11-05 Continental Pharma Fremgangsmaade til fremstilling af fenyl tylaminderivater
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE3325875A1 (de) * 1983-07-18 1985-01-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue 1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
TW203049B (xx) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US6075040A (en) 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
ATE215369T1 (de) 1996-09-05 2002-04-15 Lilly Co Eli Carbazolanaloge als selektive beta3-adrenergische agonisten
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
ES2316559T3 (es) 2001-04-18 2009-04-16 Euro-Celtique S.A. Compuestos espiroindeno y espiroindano.
CA2444634C (en) 2001-04-18 2011-06-07 R. Richard Goehring Spiropyrazole compounds
HUP0401109A3 (en) 2001-04-18 2007-12-28 Euro Celtique Sa Nociceptin analogs, their use and pharmaceutical compositions containing them
DK1975164T3 (da) * 2001-04-18 2010-05-25 Euro Celtique Sa Octahydrobenzimidazolon-forbindelser som analgetika
KR100729242B1 (ko) 2001-04-18 2007-06-15 유로-셀티크 소시에떼 아노뉨 노시셉틴 유사체
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
MXPA05005661A (es) * 2002-11-27 2005-11-23 Artesian Therapeutics Inc Compuestos con actividad antagonista o antagonista parcial mixta inhibidora de fosfodiesterasa y beta-adrenergica para el tratamiento de insuficiencia cardiaca.
US20070117978A1 (en) * 2002-12-23 2007-05-24 Artesian Therapecutics, Inc Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
DE102004001413A1 (de) * 2004-01-09 2005-08-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Hydroxymethyl-4-Hydroxy-Phenyl-Derivate zur Behandlung von chronisch obstruktiver Lungenerkrankung
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
DE102004021779A1 (de) * 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
EP1830852A2 (en) * 2004-11-30 2007-09-12 Artesian Therapeutics, Inc. Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
CA2588947A1 (en) * 2004-11-30 2006-06-08 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
DE102005007654A1 (de) * 2005-02-19 2006-08-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
PL1917253T3 (pl) * 2005-08-15 2015-06-30 Boehringer Ingelheim Int Sposób wytwarzania betamimetyków
DE102005052127A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052102A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052101A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1986644A1 (de) * 2006-02-16 2008-11-05 Boehringer Ingelheim International GmbH Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
PE20080142A1 (es) 2006-03-15 2008-04-14 Boehringer Ingelheim Int Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion
US20090324510A1 (en) 2006-08-07 2009-12-31 Boehringer Ingelheim International Gmbh Drug combinations for the treatment of respiratory tract diseases
US9604926B2 (en) 2007-08-16 2017-03-28 The University Of Mississippi Highly selective sigma receptor radioligands
US8686008B2 (en) * 2007-08-16 2014-04-01 The University Of Mississippi Highly selective sigma receptor ligands
WO2009026227A2 (en) * 2007-08-16 2009-02-26 The University Of Mississippi Highly selective sigma receptor ligands

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA631296A (en) * 1961-11-21 L. Clark Robert Substituted benzimidazolones
CH149009A (de) * 1929-08-10 1931-08-15 Chem Ind Basel Verfahren zur Darstellung einer N-substituierten Verbindung der Pyridonreihe.
US2857394A (en) * 1957-05-10 1958-10-21 Ciba Pharm Prod Inc Heterocyclic compounds
NL284529A (xx) * 1961-10-24
FR1516714A (fr) * 1962-11-07 1968-02-05 Bayer Ag Procédé de préparation de dérivés de l'imidazolidine
FR1384708A (fr) * 1963-11-21 1965-01-08 Thomson Houston Comp Francaise Perfectionnements aux dispositifs de mise en place d'objets
BE659364A (xx) * 1964-02-05
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
FR1573739A (xx) * 1968-07-26 1969-07-04
US3984405A (en) * 1971-06-28 1976-10-05 E. R. Squibb & Sons, Inc. Anti-inflammatory agents
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
FR2168140A1 (en) * 1972-01-17 1973-08-31 Bellon Labor Sa Roger Dihydro-benzoxazine derivs - antidepressants
US3925383A (en) * 1972-12-08 1975-12-09 Janssen Pharmaceutica Nv Bicyclic imidazoles and pyrimidines
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Also Published As

Publication number Publication date
IE45300L (en) 1977-09-09
DD130037A5 (de) 1978-03-01
MY8500079A (en) 1985-12-31
IL51627A0 (en) 1977-05-31
NO147950B (no) 1983-04-05
CH630358A5 (de) 1982-06-15
JPS52108970A (en) 1977-09-12
CH630361A5 (de) 1982-06-15
NZ183536A (en) 1981-11-19
HK12884A (en) 1984-02-24
FR2343731B1 (xx) 1982-02-26
GB1571231A (en) 1980-07-09
ES466605A1 (es) 1978-10-01
SU698530A3 (ru) 1979-11-15
ZA771412B (en) 1978-11-29
RO76589A (ro) 1981-04-30
NO147950C (no) 1983-07-13
BG28053A4 (en) 1980-02-25
CA1086317A (en) 1980-09-23
US4215119A (en) 1980-07-29
FR2372810A1 (fr) 1978-06-30
FI69070C (fi) 1985-12-10
JPS6172A (ja) 1986-01-06
CH630362A5 (de) 1982-06-15
BG28051A4 (en) 1980-02-25
ES456622A1 (es) 1978-03-16
ES466599A1 (es) 1978-10-01
ES466602A1 (es) 1978-10-01
LU76898A1 (xx) 1978-06-01
PH16149A (en) 1983-07-12
YU62377A (en) 1982-10-31
CH630360A5 (de) 1982-06-15
US4363814A (en) 1982-12-14
RO79706A (ro) 1982-08-17
PT66282B (pt) 1979-01-17
PH16110A (en) 1983-06-30
ES466601A1 (es) 1978-10-01
ES466598A1 (es) 1978-10-01
PL196505A1 (pl) 1979-06-18
CS209435B2 (en) 1981-12-31
ES466603A1 (es) 1978-10-01
RO70569A (ro) 1981-11-24
BG28052A4 (en) 1980-02-25
CS220320B2 (en) 1983-03-25
GR64553B (en) 1980-04-14
ES466606A1 (es) 1978-10-01
HU177953B (en) 1982-02-28
ES466604A1 (es) 1978-10-01
PT66282A (pt) 1977-04-01
NO770804L (no) 1977-09-12
CH630359A5 (de) 1982-06-15
SE7702609L (sv) 1977-10-11
BE852223A (fr) 1977-09-08
SE435059B (sv) 1984-09-03
CH630363A5 (de) 1982-06-15
NL7702403A (nl) 1977-09-13
MX4878E (es) 1982-11-26
SU676163A3 (ru) 1979-07-25
SU685149A3 (ru) 1979-09-05
FR2343731A1 (fr) 1977-10-07
SG55583G (en) 1984-07-27
FR2372810B1 (xx) 1982-11-26
AT360542B (de) 1981-01-12
PL111240B1 (en) 1980-08-30
CH630364A5 (de) 1982-06-15
US4271158A (en) 1981-06-02
BG27743A3 (en) 1979-12-12
AU515953B2 (en) 1981-05-14
FI69070B (fi) 1985-08-30
PL112937B1 (en) 1980-11-29
ATA122377A (de) 1980-06-15
PH17635A (en) 1984-10-18
SU683616A3 (ru) 1979-08-30
IE45300B1 (en) 1982-07-28
ES466600A1 (es) 1978-10-01
CH630365A5 (de) 1982-06-15
DK102177A (da) 1977-09-10
US4154829A (en) 1979-05-15
DE2609645A1 (de) 1977-09-15
FI770586A (xx) 1977-09-10
AU2300977A (en) 1978-09-14

Similar Documents

Publication Publication Date Title
IL51627A (en) Aminoalkylene benzimidazolidin-2-one,tetrahydroquinole-2-one,benzoxazol-2-one,1,4-benyoxazine-3-one and phenylimidazolidin-2-one derivatives,their preparation and pharmaceuti-cal compositions containing them
IL53639A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL51463A (en) Insecticidal compositions containing n-benzyl-n-methyl-2-propynylamine derivatives,several novel n-benzyl-n-methyl-2-propynylamine derivatives and their preparation
IL53043A (en) N-heterocyclylalkyl-(1-aryloxy-2-hydroxy-3-amino-propane)derivatives,their preparation and pharmaceutical compositions containing them
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
IL51865A0 (en) New fluoroacylresorcin derivatives their preparation and compositions containing them
NZ185965A (en) 5'-deoxy-5-fluor ocytidine, 5'-deoxy-5-fluoro-uridine and pharmaceutical compositions
IL51309A0 (en) New 1,2-benzisothiazolin-3-ones,their preparation and pharmaceutical compositions containing them
IL49325A (en) 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them
IL51339A (en) 3-(substituted)methylene-4-oxa-1-azabicyclo(3.2.0)heptan-7-one derivatives their preparation and pharmaceutical compositions containing them
IL52466A (en) 7(2-acyl-2-hydroxyiminoacetamido)-3-tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
NZ184288A (en) Ceutical compositions 10,19-dihydro-vitamin d derivatives preparation and pharma
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
IL52717A (en) Derivatives of2-phenylamino-imidazoline-(2),their preparation and pharmaceutical compositions containing them
IL52857A (en) Oxo-benzopyrane derivatives,their preparation and pharmaceutical compositions containing them
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
IL55104A (en) 1,2,4-oxadiazole derivatives,their preparation and pharmaceutical compositions containing them
IL51468A (en) 17 -hydroxy- -d-homosteroid derivatives,their preparation and pharmaceutical compositions containing them
IL52165A (en) 2-cyano-2-oximinoacetamide derivatives, their preparation and fungicidal compositions containing them
IL50105A0 (en) 1-phenyl-1,3,5,7-tetraaza-4-sulphahept-1-en-6-one derivatives,their preparation and pesticidal compositions containing them
NZ185295A (en) 9-chloroprednisolone derivatives and pharmaceutical compositions
NZ184367A (en) 2-vinyl-chromone derivatives and pharmaceutical compositions